98%
921
2 minutes
20
Introduction: The increasing use of biodegradable plastics has led to the inevitable human consumption of biodegradable microplastics (MPs). These MPs can be degraded and absorbed into various organs and tissues via the gastrointestinal tract, with the liver being the primary target for digestion and absorption.
Objectives: This study aimed to investigate the toxic effects and mechanisms of biodegradable MPs on the liver following gastrointestinal degradation.
Methods: Polylactic acid (PLA) was used as a representative bioplastic. We simulated pristine and partially degraded states using polymeric and oligomeric PLA MPs. Mice were exposed to these MPs via 28-day repeated gavage administration at environmentally realistic concentrations. In vivo multi-omics analyses, combined with in vitro studies, were employed to explore underlying mechanisms.
Results: Exposure to PLA oligomers and polymers disrupted gut microbiota, triggering an increase in plasma and hepatic uric acid levels in the mice. Elevated uric acid levels, in turn, upregulated the Hsd17b13 mRNA expression in the liver. This cascade was linked to an accumulation of hepatic triglycerides, triggering liver inflammation and promoting the progression of fibrosis. The clearance of the intestinal microbiota mitigated PLA MP-induced liver injury in mice. In HepG2 cells, PLA oligomers and polymers did not enhance the HSD17B13 mRNA expression or increase cellular lipid droplet formation. Conversely, the presence of uric acid upregulated the HSD17B13 and augmented lipid droplet production. Furthermore, simultaneous exposure to PLA particles and uric acid did not intensify lipid accumulation or lipid droplet formation within these cells.
Conclusion: Our findings demonstrate that PLA MP-induced liver damage is mediated by gut microbiota-driven elevation of uric acid. This highlights the critical role of systemic factors, particularly gut microbiota, in assessing the hepatotoxicity of PLA MPs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jare.2025.08.055 | DOI Listing |
Int J Infect Dis
September 2025
Department of Laboratory Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China. Electronic address:
Prototheca, a genus of opportunistic pathogenic microalgae, can cause protothecosis in humans and animals, manifesting as cutaneous lesions or disseminated/systemic infections. This report describes a rare case of Prototheca wickerhamii toe infection in a 78-year-old Chinese male, presenting initially as gouty arthritis. The patient, who worked in fish farming with frequent water exposure, had a history of herpes zoster and hypertension.
View Article and Find Full Text PDFJ Adv Res
September 2025
National Medical Products Administration (NMPA) Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Toxicology, School of Public Health, Southern Medical University, Guangzhou, China. Electronic address: huangzhenlie85825
Introduction: The increasing use of biodegradable plastics has led to the inevitable human consumption of biodegradable microplastics (MPs). These MPs can be degraded and absorbed into various organs and tissues via the gastrointestinal tract, with the liver being the primary target for digestion and absorption.
Objectives: This study aimed to investigate the toxic effects and mechanisms of biodegradable MPs on the liver following gastrointestinal degradation.
Lipids Health Dis
September 2025
Department of Digestive Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, No. 19 Renmin Road, Zhengzhou, 450000, P.R. China.
Background: Obesity has emerged as a critical global public health challenge. Postmenopausal women experience significantly elevated risks of metabolic disorders and a marked increase in obesity prevalence due to declining estrogen levels. The uric acid to high-density lipoprotein cholesterol ratio (UHR), an emerging biomarker for metabolic syndrome, is gaining clinical recognition.
View Article and Find Full Text PDFInt J Pharm
September 2025
Dipartimento Di Chimica e NIS, Università di Torino, via P. Giuria 7, 10125 Torino, Italy.
Gout, which affects 3-6 % of Western populations, has well-established therapies but still lacks agents that directly target monosodium urate (MSU) deposits. This study investigates a novel strategy employing cyclodextrins (CDs) and hyperbranched cyclodextrin-based polymers (HBCD-Pol) to both mobilize and prevent MSU formation. Among the CDs tested, HPβ-CD exhibited the strongest uric acid (UA) complexation at 25 °C, while HBCD-Pol showed superior performance by chelating Na ions.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, 266001, PR China. Electronic address:
The rising prevalence of hyperuricemia and associated complications present a substantial global health challenge. Fucoidan, a natural sulfate-rich polysaccharide degraded by gut microbiota, is under investigation as a potential therapeutic agent for reducing uric acid levels. However, the precise mechanism underlying its effects remains unclear.
View Article and Find Full Text PDF